Pallavi Joshi, Karen T Duong, Louis A Trevisan, Kirsten M Wilkins
{"title":"Evaluation and Management of Alcohol use Disorder among Older Adults.","authors":"Pallavi Joshi, Karen T Duong, Louis A Trevisan, Kirsten M Wilkins","doi":"10.1007/s13670-021-00359-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>The prevalence of alcohol use disorder (AUD) among older adults in the United States is rising, but remains underdiagnosed, underreported, and inadequately managed. This review highlights the medical, social, and cultural factors of AUD in older adults and provides guidelines for its screening, evaluation, and management.</p><p><strong>Recent findings: </strong>The COVID-19 pandemic has created additional challenges and barriers to care, as older adults may have disproportionate worsening of anxiety, depression, and substance use resulting from increased isolation related to physical distancing and shelter-in-place guidelines.</p><p><strong>Summary: </strong>All older adults should be routinely screened for AUD with standardized screening tools. If a patient's screening results are positive, a clinician should conduct a brief assessment, which may be supplemented by laboratory tests. Most older adults at risk for alcohol misuse do not need specialized SUD treatment, but most can benefit from Screening, Brief Intervention, and Referral to Treatment (SBIRT) to prevent substance misuse before it occurs. Medications for the treatment of AUD in older adults include naltrexone, acamprosate, disulfiram, gabapentin and topiramate. Psychosocial treatments, including mutual help groups, are equally important.</p>","PeriodicalId":38089,"journal":{"name":"Current Geriatrics Reports","volume":"10 3","pages":"82-90"},"PeriodicalIF":1.1000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13670-021-00359-5","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Geriatrics Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13670-021-00359-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 7
Abstract
Purpose of review: The prevalence of alcohol use disorder (AUD) among older adults in the United States is rising, but remains underdiagnosed, underreported, and inadequately managed. This review highlights the medical, social, and cultural factors of AUD in older adults and provides guidelines for its screening, evaluation, and management.
Recent findings: The COVID-19 pandemic has created additional challenges and barriers to care, as older adults may have disproportionate worsening of anxiety, depression, and substance use resulting from increased isolation related to physical distancing and shelter-in-place guidelines.
Summary: All older adults should be routinely screened for AUD with standardized screening tools. If a patient's screening results are positive, a clinician should conduct a brief assessment, which may be supplemented by laboratory tests. Most older adults at risk for alcohol misuse do not need specialized SUD treatment, but most can benefit from Screening, Brief Intervention, and Referral to Treatment (SBIRT) to prevent substance misuse before it occurs. Medications for the treatment of AUD in older adults include naltrexone, acamprosate, disulfiram, gabapentin and topiramate. Psychosocial treatments, including mutual help groups, are equally important.
期刊介绍:
This journal aims to offer in-depth review articles on the most recent innovative publications in geriatrics and gerontology. By providing clear, insightful contributions by international experts, the journal intends to serve clinicians and researchers involved in the diagnosis, management, treatment, prevention, and study of patients affected by age-related conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as the age-related change in cognitive function, the influence of genetics on neurodegenerative disorders, and traumatic brain injury and dementia. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board of more than 20 members reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. We also provide commentaries from well-known figures in the field.